SkinBioTherapeutics plc (FRA:5KW)

SkinBioTherapeutics Revenue

In the fiscal year ending June 30, 2025, SkinBioTherapeutics had annual revenue of 4.64M GBP with 283.74% growth. SkinBioTherapeutics had revenue of 3.06M in the half year ending June 30, 2025, with 5,459.30% growth.

• Revenue: 4.64M GBP
• Revenue Growth: +283.74%
• P/S Ratio: 11.85
• Revenue / Employee: 113.13K GBP
• Employees: 41
• Market Cap: 64.12M EUR

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	4.64M	3.43M	283.74%
Jun 30, 2024	1.21M	1.08M	815.26%
Jun 30, 2023	132.06K	57.30K	76.64%
Jun 30, 2022	74.76K	-	-
Jun 30, 2021	-	-	-